Scaffold Hopping-Guided Design of Novel PIM-1 Inhibitors with Anticancer Activities
Open Access
Abstract
PIM kinases, as members of the serine/threonine kinase family, regulate key cellular processes such as proliferation, apoptosis, and metabolism by phosphorylating multiple substrates, making them important therapeutic targets for cancer treatment. In this study, we reported a series of structurally novel PIM-1 kinase inhibitors based on a scaffold-hopping strategy. After multiple rounds of structural optimization, the highly active compound C2 was obtained, exhibiting an IC50 of 33.02 ± 1.31 nM against PIM-1 kinase. Molecular docking results revealed that compound C2 stably bound to the hydrophobic cavity of the PIM-1 protein and formed hydrogen bond interactions with polar residues in the hinge region, thereby effectively inhibiting kinase activity. In vitro antitumor assessment demonstrated significant proliferation inhibition of the hematological tumor cell line MM.1S (IC50 = 1.87 μM), comparable to the positive control SGI-1776 (IC50 = 1.71 μM). In addition, compound C2 possessed favorable drug-like properties and excellent stability in simulated gastrointestinal fluids and rat plasma. This study provides promising lead compounds for the development of novel PIM-1-targeted anticancer drugs, which can be further optimized.Keywords
Funding Information
- National Natural Science Foundation of China (82273768)
- National Natural Science Foundation of China (82574254)
This publication has 42 references indexed in Scilit:
- The landscape of innovative oncology drug targetsDrug Discovery Today, 2025
- m6A readers: Promising therapeutic targets in cancer treatmentActa Pharmaceutica Sinica B, 2025
- Design, Synthesis, and 2D QSAR Analysis of Some Novel Pyrazolo[1,5‐a]pyrimidine Derivatives as Pim‐1 Kinase Inhibitors for the Treatment of MCF‐7 Breast CancerDrug Development Research, 2025
- Mixed Lineage Kinase Domain‐Like Protein (MLKL): From Mechanisms to Therapeutic OpportunitiesAdvanced Science, 2025
- Visualize PIM‐1 Protein Function and Its Interaction With PI3K/Akt/mTOR Pathway Regulated by Its Active Sites Through FRET BiosensorsBiotechnology Journal, 2024
- Rational Identification of Novel Antibody‐Drug Conjugate with High Bystander Killing Effect against Heterogeneous TumorsAdvanced Science, 2024
- Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectivesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- The ever‐increasing importance of cancer as a leading cause of premature death worldwideCancer, 2021
- The PIM Family of Serine/Threonine Kinases in CancerMedicinal Research Reviews, 2013
- Potential roles for the PIM1 kinase in human cancer – A molecular and therapeutic appraisalEuropean Journal of Cancer, 2008